NCT02730364View on ClinicalTrials.gov

An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

February 1, 2017

Primary Completion Date

April 1, 2017

Study Completion Date

April 1, 2017

Conditions

Infections, Respiratory Tract

Interventions

DRUG

Paracetamol, phenylephrine HCl, pheniramine maleate, and vitamin C

One sachet is provided for each participant randomized to the Theraflu Night powder containing paracetamol, phenylephrine HCl, pheniramine maleate, and vitamin C as oral solution.